CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 51 filers reported holding CATALYST BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $722,000 | -1.6% | 175,751 | +3.7% | 0.07% | -10.8% |
| Q2 2021 | $734,000 | +460.3% | 169,535 | +553.8% | 0.08% | +277.3% |
| Q1 2021 | $131,000 | +63.8% | 25,932 | +105.2% | 0.02% | +69.2% |
| Q4 2020 | $80,000 | -65.5% | 12,635 | -62.9% | 0.01% | -51.9% |
| Q4 2019 | $232,000 | -22.4% | 34,047 | -16.0% | 0.03% | -18.2% |
| Q2 2019 | $299,000 | -91.3% | 40,526 | -87.3% | 0.03% | -82.6% |
| Q3 2018 | $3,449,000 | +88.1% | 319,915 | +103.6% | 0.19% | +108.8% |
| Q2 2018 | $1,834,000 | – | 157,145 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |